| Sanofi | 10% Owner | 672,778Common Stock | $12.3M | Conversion | |
|---|
| 5AM Ventures VI, L.P. | 10% Owner | 7,325,962Common Stock | $133.7M | Conversion | |
|---|
| Westlake BioPartners Fund I, L.P. | 10% Owner | 12,695,305Common Stock | $231.7M | Conversion | |
|---|
| Foresite Capital Management V, LLC | 10% Owner | 5,923,664Common Stock | $108.1M | Conversion | |
|---|
| Foresite Capital Management V, LLC | 10% Owner | 140,000Common Stock | $2.6M | Buy | |
|---|
| SEIDENBERG BETH C | Director, 10% Owner | 12,695,305Common Stock | $231.7M | Conversion | |
|---|
| Tananbaum James B. | Director, 10% Owner | 195,776Convertible Promissory Note | $3.6M | Conversion | |
|---|
| Tananbaum James B. | Director, 10% Owner | 1,484,401Series B Convertible Preferred Stock | $27.1M | Conversion | |
|---|
| Tananbaum James B. | Director, 10% Owner | 4,243,487Series A-2 Convertible Preferred Stock | $77.4M | Conversion | |
|---|
| Tananbaum James B. | Director, 10% Owner | 3,117,664Series A-2 Convertible Stock | $56.9M | Conversion | |
|---|
